InsiderClue
Insiders · Profile

DiBiase Mary

Chief Operating Officer at X4 Pharmaceuticals. Filing since 11 Feb 2022. CIK 0001880179

Company
Date
Role
Action
Shares
Amount
Of holding
XFOR X4 Pharmaceuticals, Inc
24 Jan 2025
Chief Operating Officer
Sold at will
22,258
$10.09K
4.3%
XFOR X4 Pharmaceuticals, Inc
7 Oct 2024
Chief Operating Officer
Sold at will
67,695
$38.33K
13.0%
XFOR X4 Pharmaceuticals, Inc
9 Sep 2024
Chief Operating Officer
Sold at will
2,642
$1.74K
0.9%
XFOR X4 Pharmaceuticals, Inc
11 Mar 2024
Chief Operating Officer
Sold at will
15,409
$13.59K
5.0%
XFOR X4 Pharmaceuticals, Inc
12 Feb 2024
Chief Operating Officer
Sold at will
3,683
$3.71K
1.2%
XFOR X4 Pharmaceuticals, Inc
1 Nov 2023
Chief Operating Officer
Sold on a plan
67,695
$49.42K
17.9%
XFOR X4 Pharmaceuticals, Inc
8 Sep 2023
Chief Operating Officer
Sold at will
2,642
$3.30K
1.8%
XFOR X4 Pharmaceuticals, Inc
30 Jun 2023
Chief Operating Officer
Sold at will
464
$876.96
0.3%
XFOR X4 Pharmaceuticals, Inc
23 Jun 2023
Chief Operating Officer
Sold at will
857
$1.65K
0.6%
XFOR X4 Pharmaceuticals, Inc
15 Jun 2023
Chief Operating Officer
Sold at will
857
$1.91K
0.6%
XFOR X4 Pharmaceuticals, Inc
10 Mar 2023
Chief Operating Officer
Sold, plan not stated
18,192
$15.28K
10.6%
XFOR X4 Pharmaceuticals, Inc
13 Feb 2023
Chief Operating Officer
Sold, plan not stated
4,348
$4.04K
2.5%
XFOR X4 Pharmaceuticals, Inc
17 Aug 2022
Chief Operating Officer
Sold, plan not stated
1,713
no price
1.0%
XFOR X4 Pharmaceuticals, Inc
30 Jun 2022
Chief Operating Officer
Sold, plan not stated
1,578
no price
0.9%
XFOR X4 Pharmaceuticals, Inc
24 Jun 2022
Chief Operating Officer
Sold, plan not stated
856
no price
0.5%
XFOR X4 Pharmaceuticals, Inc
16 Jun 2022
Chief Operating Officer
Sold, plan not stated
856
no price
0.5%
XFOR X4 Pharmaceuticals, Inc
11 Feb 2022
Chief Operating Officer
Sold, plan not stated
12,545
no price
13.9%
17 decisions on file.